Medpace Holdings Other Operating Income or Expenses 2014-2024 | MEDP
Medpace Holdings annual/quarterly other operating income or expenses history and growth rate from 2014 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
- Medpace Holdings other operating income or expenses for the quarter ending September 30, 2024 were $-0.193B, a 1.11% decline year-over-year.
- Medpace Holdings other operating income or expenses for the twelve months ending September 30, 2024 were $-0.777B, a 17.14% increase year-over-year.
- Medpace Holdings annual other operating income or expenses for 2023 were $-0.723B, a 46.77% increase from 2022.
- Medpace Holdings annual other operating income or expenses for 2022 were $-0.493B, a 32.04% increase from 2021.
- Medpace Holdings annual other operating income or expenses for 2021 were $-0.373B, a 27.45% increase from 2020.
| Medpace Holdings Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2023 | $-723 |
| 2022 | $-493 |
| 2021 | $-373 |
| 2020 | $-293 |
| 2019 | $-294 |
| 2018 | $-237 |
| 2017 | $-50 |
| 2016 | $-51 |
| 2015 | $-39 |
| 2014 | $-58 |
| 2013 | $-29 |
| Medpace Holdings Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-193 |
| 2024-06-30 | $-203 |
| 2024-03-31 | $-184 |
| 2023-12-31 | $-197 |
| 2023-09-30 | $-195 |
| 2023-06-30 | $-178 |
| 2023-03-31 | $-153 |
| 2022-12-31 | $-138 |
| 2022-09-30 | $-128 |
| 2022-06-30 | $-120 |
| 2022-03-31 | $-107 |
| 2021-12-31 | $-102 |
| 2021-09-30 | $-96 |
| 2021-06-30 | $-95 |
| 2021-03-31 | $-80 |
| 2020-12-31 | $-85 |
| 2020-09-30 | $-69 |
| 2020-06-30 | $-62 |
| 2020-03-31 | $-77 |
| 2019-12-31 | $-82 |
| 2019-09-30 | $-71 |
| 2019-06-30 | $-71 |
| 2019-03-31 | $-71 |
| 2018-12-31 | $-63 |
| 2018-09-30 | $-61 |
| 2018-06-30 | $-55 |
| 2018-03-31 | $-57 |
| 2017-12-31 | $-13 |
| 2017-09-30 | $-12 |
| 2017-06-30 | $-12 |
| 2017-03-31 | $-13 |
| 2016-12-31 | $-13 |
| 2016-09-30 | $-13 |
| 2016-06-30 | $-13 |
| 2016-03-31 | $-12 |
| 2015-12-31 | |
| 2015-09-30 | $-10 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.498B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $93.361B | 11.58 |
| Cencora (COR) | United States | $48.280B | 17.81 |
| DiDi Global (DIDIY) | China | $22.212B | 0.00 |
| Natera (NTRA) | United States | $22.082B | 0.00 |
| ICON (ICLR) | Ireland | $17.675B | 15.74 |
| Viatris (VTRS) | United States | $15.958B | 4.92 |
| Avantor (AVTR) | United States | $14.143B | 21.20 |
| Revvity (RVTY) | United States | $13.634B | 23.68 |
| CochLear (CHEOY) | Australia | $12.777B | 0.00 |
| Solventum (SOLV) | United States | $12.233B | 0.00 |
| BioMerieux (BMXMF) | France | $11.895B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
| HealthEquity (HQY) | United States | $9.104B | 49.41 |
| Doximity (DOCS) | United States | $8.999B | 52.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
| Life Times (LTH) | United States | $5.081B | 33.63 |
| Organon (OGN) | United States | $3.935B | 3.97 |
| Sotera Health (SHC) | United States | $3.631B | 19.42 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
| Concentras Parent (CON) | United States | $2.789B | 0.00 |
| PACS (PACS) | United States | $2.515B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
| Premier (PINC) | United States | $2.195B | 11.42 |
| GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
| Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
| Progyny (PGNY) | United States | $1.315B | 26.62 |
| Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
| CareDx (CDNA) | United States | $1.241B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
| Embecta (EMBC) | United States | $0.797B | 5.32 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.674B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| DocGo (DCGO) | United States | $0.434B | 16.35 |
| Enhabit (EHAB) | United States | $0.380B | 32.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
| ModivCare (MODV) | United States | $0.254B | 13.79 |
| LifeMD (LFMD) | United States | $0.251B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
| Biodesix (BDSX) | United States | $0.186B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| MultiPlan (MPLN) | United States | $0.112B | 0.00 |
| So-Young (SY) | China | $0.086B | 16.60 |
| Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.10 |
| IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |